Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Healthcare Stocks Dip as HSBC Downgrades Pfizer; Novartis Strikes $1.5B Biotech Deal
The NYSE Healthcare Index dropped 1.2% as HSBC cut Pfizer to hold, dragging mega-cap pharma lower. Meanwhile, Novartis announced a $1.5 bill
Versant Media Acquires Full Swing for $530M to Build Interactive Sports Platform
Versant Media is buying Full Swing, a golf-simulator platform, for $530 million in cash. The deal, expected to close in late 2026, aims to b
Blue Owl Capital Shares Jump 5.4% After Fund Buys Minority Stake in Cleveland Cavaliers
Blue Owl Capital shares jumped 5.4% after its HomeCourt Partners fund bought a minority stake in the NBA's Cleveland Cavaliers. Owner Dan Gi
BRP Opens Mega Hub to Boost Parts and Gear Sales as Aftermarket Revenue Tops C$1 Billion
BRP opened a massive distribution hub in Quebec to centralize parts and gear operations. The move targets steadier revenue from aftermarket
Rogers Pays C$4.35 Billion for Full Control of Maple Leaf Sports & Entertainment
Rogers Communications is acquiring the final 25% of Maple Leaf Sports & Entertainment for C$4.35 billion. The deal gives the telecom full co
ICG Silver & Gold Begins Drilling at Nevada's Tuscarora District, Assays Due in August
ICG Silver & Gold has kicked off a 3,000-meter Phase 1 reverse-circulation drilling program at Nevada's Tuscarora District. Initial assay re
RBC Lifts Sainsbury's Sales Forecasts on Strong Q1 and Grocery Strategy Shift
RBC Capital Markets has raised its sales forecasts for Sainsbury's through fiscal 2029 after a strong first-quarter update. The bank sees th
Novartis Bets $1.1 Billion on Myricx Bio's Cancer Drugs as Swiss Stocks Dip
Novartis agreed to buy UK biotech Myricx Bio for $1.1 billion, adding two antibody-drug conjugate cancer candidates. The Swiss Market Index
Sky's £1.6 Billion ITV Deal Raises Competition Alarm Over 70% Ad Market Share
Sky's £1.6 billion acquisition of ITV's broadcast and streaming assets could give the combined entity control over roughly 70% of the UK's l
Novartis Buys Myricx Bio for $1.1B as European Markets End Mixed
Swiss drugmaker Novartis agreed to pay $1.1 billion upfront for Myricx Bio, a private cancer biotech, with up to $400 million more in milest
Fincantieri's €600M Underwater Tech Buy Boosts Defense and Dual-Use Ambitions
Fincantieri is spending about €600 million to take majority stakes in four Italian underwater-tech companies, aiming to accelerate its 2030
UBS Maintains Sell Rating on National Beverage as Margins Face Dual Pressure
UBS reiterated its sell rating and $33 price target on National Beverage, warning that softer sales volumes and stubborn input costs will ke